SIXTH AMENDMENT AGREEMENTSecurities Purchase Agreement • November 10th, 2011 • Genta Inc De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 10th, 2011 Company Industry JurisdictionThis SIXTH AMENDMENT AGREEMENT (this “Agreement”), dated as of November 7, 2011, is made by and among GENTA INCORPORATED, a Delaware corporation (the “Company”), and the undersigned parties (each a “Holder” and collectively the “Holders”). Capitalized terms used herein and not defined shall have the meanings set forth in the Securities Purchase Agreement (as defined below).
FIFTH AMENDMENT AGREEMENTFifth Amendment Agreement • November 10th, 2011 • Genta Inc De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 10th, 2011 Company Industry JurisdictionThis FIFTH AMENDMENT AGREEMENT (this “Agreement”), dated as of October 31, 2011, is made by and among GENTA INCORPORATED, a Delaware corporation (the “Company”), and the undersigned parties (each a “Holder” and collectively the “Holders”). Capitalized terms used herein and not defined shall have the meanings set forth in the Securities Purchase Agreement (as defined below).
FOURTH AMENDMENT AGREEMENTFourth Amendment Agreement • November 10th, 2011 • Genta Inc De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 10th, 2011 Company Industry JurisdictionThis FOURTH AMENDMENT AGREEMENT (this “Agreement”), dated as of October 24, 2011, is made by and among GENTA INCORPORATED, a Delaware corporation (the “Company”), and the undersigned parties (each a “Holder” and collectively the “Holders”). Capitalized terms used herein and not defined shall have the meanings set forth in the Securities Purchase Agreement (as defined below).
AMENDMENT AGREEMENTAmendment Agreement • November 10th, 2011 • Genta Inc De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 10th, 2011 Company Industry JurisdictionThis AMENDMENT AGREEMENT (this “Agreement”), dated as of October 7, 2011, is made by and among GENTA INCORPORATED, a Delaware corporation (the “Company”), and the undersigned parties whose names are set forth on Exhibit A attached hereto (each a “Holder” and collectively the “Holders”). Capitalized terms used herein and not defined shall have the meanings set forth in the Securities Purchase Agreement (as defined below).
SECOND AMENDMENT AGREEMENTSecond Amendment Agreement • November 10th, 2011 • Genta Inc De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 10th, 2011 Company Industry JurisdictionThis SECOND AMENDMENT AGREEMENT (this “Agreement”), dated as of October 12, 2011, is made by and among GENTA INCORPORATED, a Delaware corporation (the “Company”), and the undersigned parties (each a “Holder” and collectively the “Holders”). Capitalized terms used herein and not defined shall have the meanings set forth in the Securities Purchase Agreement (as defined below).
THIRD AMENDMENT AGREEMENTThird Amendment Agreement • November 10th, 2011 • Genta Inc De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 10th, 2011 Company Industry JurisdictionThis THIRD AMENDMENT AGREEMENT (this “Agreement”), dated as of October 19, 2011, is made by and among GENTA INCORPORATED, a Delaware corporation (the “Company”), and the undersigned parties (each a “Holder” and collectively the “Holders”). Capitalized terms used herein and not defined shall have the meanings set forth in the Securities Purchase Agreement (as defined below).